Reynald Allam, MD
Undersea and Hyperbaric Medicine · Clearwater, FLNPI 1831293141
Payments from drug & device makers
What this record shows
Organogenesis Inc. accounts for 69.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2020 at $1,018 and has fallen 79.2% since, to $211 in 2025.
Across 42 payments — averaging $47.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$1K
- Smith+Nephew$249
- Kerecis Limited$188
- Next Science LLC$52
- Reapplix Inc.$40
- Cashflow Solutions, LLC$33
- plus $50 from 3 others
What the payments were for
- Speaking & faculty fees$80040%
- Food & beverage$1,19660%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 15 | $1,384 |
| Smith+Nephew | 11 | $249 |
| Kerecis Limited | 6 | $188 |
| Next Science LLC | 3 | $52 |
| Reapplix Inc. | 2 | $40 |
| Cashflow Solutions, LLC | 2 | $33 |
| Triad Life Sciences Inc. | 1 | $18 |
| Mimedx Group, Inc. | 1 | $18 |
| Urgo Medical North America, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$1,102
- Kerecis Omega3 Wound$125
How this compares
$1,996 in reported general payments places this provider in the 70th percentile of 32 undersea and hyperbaric medicine providers in Florida.
See all undersea and hyperbaric medicine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 34 | $1,730 |
| Metronidazole | 22 | $669 |
| Doxycycline Hyclate | 64 | $605 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 40 | $354 |
| Pentoxifylline | 12 | $321 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 44 | $299 |
| Clobetasol Propionate | 11 | $283 |
| Levofloxacin | 46 | $246 |
| SsdSilver Sulfadiazine | 14 | $230 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $215 |
| Cefadroxil | 25 | $192 |
| Triamcinolone Acetonide | 42 | $124 |
| Ciprofloxacin Hcl | 20 | $119 |
| Tramadol Hcl | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Clearwater
- Stephen PappachenLakeland$1.3M
- Juan BravoLakeland$6K
- Magaly RodriguezTampa$6K
- Lawrence BachlePunta Gorda$4K
- Edgar RhodesJacksonville$3K
- Walter ConlanOrlando$3K
- Paolina PantchevaKissimmee$2K
- Paul JohnsonDaytona Beach$2K
- Blane ShatkinPembroke Pines$2K
- Matthew EllisGainesville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.